Moderna, Novavax, Pfizer Shares Fall on Nomination of Anti-Vaxxer as US Health Secretary
MT Newswires Live11-15
Moderna (MRNA), Novavax (NVAX) and Pfizer (PFE) shares fell in Friday's premarket activity following losses on Thursday after US president-elect Donald Trump nominated longtime anti-vaccination activist Robert F. Kennedy Jr. to lead the Department of Health and Human Services.
Shares of Moderna were down more than 2% pre-bell after closing down 5.6% Thursday. Novavax was down almost 2% premarket after falling 7% on Thursday. Pfizer, with a more diverse portfolio of offerings, was down less than 1% pre-bell, after declining 2.6% a day earlier.
Kennedy has opposed childhood vaccinations and has spoken out against vaccines, news outlets reported.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
